Scienture Holdings, Inc. (SCNX)Healthcare | Pharmaceutical Retailers | Tampa, United States | NasdaqCM
0.40 USD
+0.01
(1.282%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.39 -0.01 (-0.005%) ⇩ (April 17, 2026, 7:35 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:26 p.m. EDT
Despite recent price surges driven by FDA approvals and fever-pitch news on its Arbli product, the stock carries overwhelming fundamental warnings: negative earnings, positive free cash flow burn, and a negative short-term price forecast. The recent price rally is a classic 'buy the news' spike that has already exceeded analyst targets, making a continued near-term momentum play highly risky given the deteriorating underlying fundamentals and volatile technicals. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.108928 |
| AutoETS | 0.179540 |
| AutoARIMA | 0.189173 |
| MSTL | 0.194599 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 20.00 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.026 |
| Excess Kurtosis | 1.24 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2024-07-18 |
| Last Dividend Date | 2024-07-18 |
| Debt to Equity Ratio | 0.034 |
| Revenue per Share | 0.028 |
| Market Cap | 16,049,173 |
| Forward P/E | -1.88 |
| Previous Name | TRxADE HEALTH, Inc. |
| Website | https://scienture.com |
| Date | Dividend | Yield % |
|---|---|---|
| 2024-07-19 | 1.5 | 10.176391 |
| 2024-03-25 | 8.0 | 90.153662 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5292014 |
| Address1 | 6,308 Benjamin Rd |
| Address2 | Suite 708 |
| All Time High | 720.0 |
| All Time Low | 0.238 |
| Ask | 0.2651 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 580,490 |
| Average Daily Volume3 Month | 3,069,077 |
| Average Volume | 3,069,077 |
| Average Volume10Days | 580,490 |
| Bid | 0.3227 |
| Bid Size | 1 |
| Book Value | 1.726 |
| City | Tampa |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.395 |
| Current Ratio | 2.894 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.404 |
| Day Low | 0.3687 |
| Debt To Equity | 0.034 |
| Display Name | Scienture |
| Dividend Date | 1,721,779,200 |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,596,800 |
| Ebitda | -15,788,946 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.596 |
| Enterprise To Revenue | 21.805 |
| Enterprise Value | 9,411,301 |
| Eps Current Year | -0.72 |
| Eps Forward | -0.21 |
| Eps Trailing Twelve Months | -2.7 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,721,347,200 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.40656 |
| Fifty Day Average Change | -0.011559993 |
| Fifty Day Average Change Percent | -0.02843367 |
| Fifty Two Week Change Percent | -52.92014 |
| Fifty Two Week High | 2.6 |
| Fifty Two Week High Change | -2.205 |
| Fifty Two Week High Change Percent | -0.84807694 |
| Fifty Two Week Low | 0.238 |
| Fifty Two Week Low Change | 0.157 |
| Fifty Two Week Low Change Percent | 0.65966386 |
| Fifty Two Week Range | 0.238 - 2.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,391,697,000,000 |
| Float Shares | 32,792,724 |
| Forward Eps | -0.21 |
| Forward P E | -1.8809525 |
| Free Cashflow | -362,075 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.76801 |
| Gross Profits | 331,482 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.21875 |
| Held Percent Institutions | 0.03716 |
| Implied Shares Outstanding | 40,630,816 |
| Industry | Pharmaceutical Retailers |
| Industry Disp | Pharmaceutical Retailers |
| Industry Key | pharmaceutical-retailers |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,721,347,200 |
| Last Dividend Value | 1.5 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,687,392,000 |
| Last Split Factor | 1:15 |
| Long Business Summary | Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida. |
| Long Name | Scienture Holdings, Inc. |
| Market | us_market |
| Market Cap | 16,049,173 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_698186627 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -41,512,264 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 16,049,171 |
| Number Of Analyst Opinions | 1 |
| Open | 0.39 |
| Operating Cashflow | -13,379,683 |
| Operating Margins | 18.69817 |
| Payout Ratio | 0.0 |
| Phone | 800 261 0281 |
| Post Market Change | -0.005000025 |
| Post Market Change Percent | -1.2658291 |
| Post Market Price | 0.39 |
| Post Market Time | 1,776,468,917 |
| Prev Name | TRxADE HEALTH, Inc. |
| Previous Close | 0.39 |
| Price Eps Current Year | -0.5486111 |
| Price Hint | 4 |
| Price To Book | 0.22885285 |
| Price To Sales Trailing12 Months | 37.18452 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.703 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.00500003 |
| Regular Market Change Percent | 1.28206 |
| Regular Market Day High | 0.404 |
| Regular Market Day Low | 0.3687 |
| Regular Market Day Range | 0.3687 - 0.404 |
| Regular Market Open | 0.39 |
| Regular Market Previous Close | 0.39 |
| Regular Market Price | 0.395 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 357,843 |
| Return On Assets | -0.10742 |
| Return On Equity | -0.55649 |
| Revenue Per Share | 0.028 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 40,630,815 |
| Shares Percent Shares Out | 0.0547 |
| Shares Short | 2,223,915 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,393,320 |
| Short Name | Scienture Holdings, Inc. |
| Short Percent Of Float | 0.065799996 |
| Short Ratio | 0.29 |
| Source Interval | 15 |
| State | FL |
| Symbol | SCNX |
| Target High Price | 1.5 |
| Target Low Price | 1.5 |
| Target Mean Price | 1.5 |
| Target Median Price | 1.5 |
| Total Cash | 6,662,008 |
| Total Cash Per Share | 0.164 |
| Total Debt | 24,137 |
| Total Revenue | 431,609 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.7 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.83352 |
| Two Hundred Day Average Change | -0.43851998 |
| Two Hundred Day Average Change Percent | -0.5261061 |
| Type Disp | Equity |
| Volume | 357,843 |
| Website | https://scienture.com |
| Zip | 33,634 |